EODData

NASDAQ, KYTX: Kyverna Therapeutics Inc

29 Jan 26 15:59
LAST:

8.195

CHANGE:
 0.17
OPEN:
8.550
HIGH:
8.550
ASK:
0.000
VOLUME:
543.9K
CHG(%):
2.03
PREV:
8.380
LOW:
8.030
BID:
0.000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
29 Jan 268.4408.4908.0308.210700.3K
28 Jan 269.3609.3968.2158.3801.31M
27 Jan 268.9109.5608.9109.280849.1K
26 Jan 269.7009.7008.8008.8801.17M
23 Jan 2610.39010.5009.7209.760546.0K
22 Jan 269.53010.5509.53010.5101.27M
21 Jan 269.0409.5008.7509.4801.3M
20 Jan 268.0609.1608.0409.0201.01M
16 Jan 268.7508.9008.3258.360571.7K
15 Jan 269.3209.3208.5208.720622.2K

PROFILE

Name:Kyverna Therapeutics Inc
About:Kyverna Therapeutics, Inc., clinical-stage biopharmaceutical company, focuses on developing cell therapies for patients with autoimmune diseases. The company's lead product candidate is KYV-101, an autologous CD19 CAR T-cell product candidate for the treatment of stiff person syndrome, myasthenia gravis, lupus nephritis, and rapid whole blood process. It is also developing KYV-102, an autologous CD19 CAR T-cell product candidate with whole blood rapid manufacturing, as well as KYV-201, an allogeneic CD19 CAR T-cell product candidate. It has a license and collaboration agreement with Intellia Therapeutics, Inc. The company was formerly known as BAIT Therapeutics, Inc. and changed its name to Kyverna Therapeutics, Inc. in October 2019. Kyverna Therapeutics, Inc. was incorporated in 2018 and is headquartered in Emeryville, California.
Sector:Healthcare
Industry:Biotechnology
Address:5980 Horton Street, EmeryVille, CA, United States, 94608
Website:https://kyvernatx.com
CIK:0001994702
ISIN:US5019761049
FIGI:BBG00RCYMHR1

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:-2.07 
Forward P/E:-2.43 
PEG Ratio:-0.05 
Price to Book:2.51 
Return on Assets:-0.42 
Return on Equity:-0.48 
EPS Ratio:-4.09 
Shares:59.61M 
Market Cap:488.48M 

TECHNICAL INDICATORS

MA5:8.908.6%
MA10:9.0610.6%
MA20:8.827.6%
MA50:8.372.1%
MA100:7.2912.4%
MA200:5.1758.4%
RSI14:48.33
WPR14:-100.00 
MTM14:-0.11
ROC14:-0.01 
ATR:0.81 
Week High:10.5528.7%
Week Low:8.032.1%
Month High:10.5528.7%
Month Low:7.7758.4%
Year High:13.6766.8%
Year Low:1.78360.4%
Volatility:168.45